Product Name:
Betamin Thiamine Hydrochloride - 100 Tablets
Product Description:
Betamin (Thiamine hydrochloride or Vitamin B1) is a trusted medication designed to address thiamine deficiency. Thiamine, an essential member of the B-vitamin family, plays a pivotal role in numerous vital metabolic functions within the body. Thiamine deficiency can manifest due to various factors, such as restricted diets, gastrointestinal ailments, major burns, kidney or liver complications, thyroid issues, alcoholism, injectable nutrition administration, diabetes, or the development of abnormal breast tissue.
Usage and Indications:
Betamin is primarily recommended to combat thiamine (Vitamin B1) deficiency. Your healthcare provider or pharmacist may suggest Betamin for alternative purposes, depending on your unique medical circumstances. If you have any questions about its suitability for your needs, please consult your doctor or pharmacist.
Active Ingredients:
Each Betamin tablet contains Thiamine hydrochloride (Vitamin B1) as its active ingredient, expertly formulated to address thiamine deficiency effectively.
Dosage Instructions:
The standard dosage for Betamin is 1/2 to 1 tablet daily. However, please follow your healthcare provider's specific instructions. Swallow the tablet with a full glass of water or another suitable liquid.
Safety Precautions and Warnings:
It's essential to be aware that the manufacturer, Sanofi, has initiated a voluntary recall of one specific batch of Betamin tablets (Thiamine hydrochloride 100 mg). The reason for this recall is the potential presence of Plavix/Iscover (clopidogrel 75 mg) tablets in some bottles from this batch. The affected batch number is 124E001 with an expiry date of 02/18. This recall does not affect any other batches.
Storage and Shelf Life:
Store Betamin Thiamine Hydrochloride tablets in a cool, dry place away from direct sunlight and moisture. Ensure they are out of reach of children. Please check the expiration date on the packaging and do not use the product if it has expired.
